ROCHE HOLDING LTD (RHHBF)
Clinical trial NCT06068985 updates: 1. completion date: 2032-04-01 → 2032-11-01 2. primary completion date: 2026-04-01 → 2027-04-01
Clinical trial NCT06068985 updates: 1. completion date: 2032-04-01 → 2032-11-01 2. primary completion date: 2026-04-01 → 2027-04-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical